Literature DB >> 20829091

Gastrointestinal dysfunction in Parkinson's disease.

Ronald F Pfeiffer1.   

Abstract

In recent years, an increasingly detailed picture of gastrointestinal dysfunction in the setting of Parkinson's disease has emerged. Abnormalities of function may occur at virtually all levels of the gastrointestinal tract. Weight loss, dental deterioration, salivary excess, dysphagia, gastroparesis, decreased bowel movement frequency, and anorectal dysfunction all may occur. The pathophysiologic basis for this dysfunction entails both central and enteric nervous system involvement.
© 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20829091     DOI: 10.1016/j.parkreldis.2010.08.003

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  70 in total

1.  Mice overexpressing wild-type human alpha-synuclein display alterations in colonic myenteric ganglia and defecation.

Authors:  L Wang; I Magen; P-Q Yuan; S R Subramaniam; F Richter; M-F Chesselet; Y Taché
Journal:  Neurogastroenterol Motil       Date:  2012-07-11       Impact factor: 3.598

2.  Involvement of catecholaminergic neurons in motor innervation of striated muscle in the mouse esophagus.

Authors:  Piet van der Keylen; Fabian Garreis; Ruth Steigleder; Daniel Sommer; Winfried L Neuhuber; Jürgen Wörl
Journal:  Histochem Cell Biol       Date:  2016-01-21       Impact factor: 4.304

Review 3.  Gut dysfunction in Parkinson's disease.

Authors:  Adreesh Mukherjee; Atanu Biswas; Shyamal Kumar Das
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

Review 4.  Gastrointestinal features of Parkinson's disease.

Authors:  Leslie J Cloud; James G Greene
Journal:  Curr Neurol Neurosci Rep       Date:  2011-08       Impact factor: 5.081

Review 5.  Parkinson's disease as a multisystem disorder.

Authors:  Lisa Klingelhoefer; H Reichmann
Journal:  J Neural Transm (Vienna)       Date:  2017-02-02       Impact factor: 3.575

Review 6.  Building a second brain in the bowel.

Authors:  Marina Avetisyan; Ellen Merrick Schill; Robert O Heuckeroth
Journal:  J Clin Invest       Date:  2015-02-09       Impact factor: 14.808

7.  Association between DRD2 and DRD3 gene polymorphisms and gastrointestinal symptoms induced by levodopa therapy in Parkinson's disease.

Authors:  M Rieck; A F Schumacher-Schuh; V Altmann; S M Callegari-Jacques; C R M Rieder; M H Hutz
Journal:  Pharmacogenomics J       Date:  2016-10-25       Impact factor: 3.550

Review 8.  Parkinson's disease.

Authors:  Timothy R Mhyre; James T Boyd; Robert W Hamill; Kathleen A Maguire-Zeiss
Journal:  Subcell Biochem       Date:  2012

9.  Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease.

Authors:  Jared T Hinkle; Kate Perepezko; Kelly A Mills; Zoltan Mari; Ankur Butala; Ted M Dawson; Alexander Pantelyat; Liana S Rosenthal; Gregory M Pontone
Journal:  Parkinsonism Relat Disord       Date:  2018-08-22       Impact factor: 4.891

10.  Macrophages are unsuccessful in clearing aggregated alpha-synuclein from the gastrointestinal tract of healthy aged Fischer 344 rats.

Authors:  Robert J Phillips; Cherie N Billingsley; Terry L Powley
Journal:  Anat Rec (Hoboken)       Date:  2013-02-26       Impact factor: 2.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.